This category needs to be renamed to be meaningful than “Miscellaneous” but it will do for now. Basically it’s intended for news, research, legal actions and other information about medical marijuana for the general, nonexpert audience: patients, jouralists, the curious, etc.
Dr. Patricia Frye summarizes a cannabis policy hearing at the House of Representatives. Dr. Frye saw strong bipartisan support for decreasing the barriers to research on cannabis medicine.
The SCC sent a poll to its membership to gauge how those within the organization were approaching the vape pen issue and EVALI. Learn more about their recommendations and considerations.
Complementary Therapies in Medicine, January 2020
—
Introduction: Over-the-counter and prescribed medical cannabis products are used by patients for various conditions including psychiatric disorders, pain management, and other neurodegenerative conditions.1 Despite this growing public interest and increasing legal availability…
The 2019 IACM conference in Berlin highlighted talks from the top professionals in the field of cannabis science. Christine Milentis reports on the history of cannabis for medical use and the rights of doctors across the globe to prescribe it.
A study published in BMC Family Practice sought to characterize the clinical practice characteristics of medical professionals who recommend cannabis.
Dr. Sarah Mann tells the tale of one of her patients who inspired the shift towards a cannabis integrated practice.
Kevin M. Takakuwa, MD and Dr. Dustin Sulak evaluate how US medical professionals received their cannabis medicine training in Mary Ann Liebert, Inc.
Genester Wilson-King, MD and Dr. Michael Eisenberg are conducting research on cannabis and sexual health at Stanford University. The survey will provide an opportunity for the general public to participate in cannabis research.
SCC member Kevin M. Takakuwa, MD outlines on the historical impact of cannabis and its relevance to pediatric practice. The article highlights how cannabis may benefit seizure disorders in children and young adults.
JAMA, 9 August 2019
—
Nearly 10% of cannabis users in the United States report using it for medicinal purposes.1 As of August 2019, 33 states and the District of Columbia have initiated policies allowing the use of cannabis or cannabinoids for the management of specific medical conditions. Yet, the…
During Pride Month, we owe it to history to recall an embarrassing, tragic twist in the relationship between AIDS activism and the medical marijuana movement.
The historical account of Dennis Peron, the medical cannabis and human rights activist who was instrumental in bringing attention to AIDS and changing cannabis policy in California.